Abstract

BackgroundVisceral leishmaniasis has emerged as an important opportunistic disease among patients infected with HIV-1. Both HIV-1 and the protozoan parasite Leishmania can productively infect cells of the macrophage-dendritic cell lineage.Methodology/Principal FindingsHere we demonstrate that Leishmania infantum amastigotes increase HIV-1 production when human primary dendritic cells (DCs) are cocultured together with autologous CD4+ T cells. Interestingly, the promastigote form of the parasite does not modulate virus replication. Moreover, we report that amastigotes promote virus replication in both cell types. Our results indicate that this process is due to secretion of parasite-induced soluble factors by DCs. Luminex micro-beads array system analyses indicate that Leishmania infantum amastigotes induce a higher secretion of several cytokines (i.e. IL-1α, IL-2, IL-6, IL-10 and TNF-α) and chemokines (i.e. MIP-1α, MIP-1β and RANTES) in these cells. Studies conducted with pentoxifylline and neutralizing antibodies revealed that the Leishmania-dependent augmentation in HIV-1 replication is due to a higher secretion of IL-6 and TNF-α.Conclusions/SignificanceAltogether these findings suggest that the presence of Leishmania within DC/T-cell conjugates leads to an enhancement of virus production and demonstrate that HIV-1 and Leishmania can establish complex interactions in such a cellular microenvironment.

Highlights

  • Leishmaniasis is today recognized as one of the world’s most important parasitic diseases, threatening 350 million people in 88 countries [1]

  • We studied the effect of Leishmania infantum on human immunodeficiency virus type-1 (HIV-1) production when dendritic cells (DCs) are cocultured with autologous CD4+ T cells

  • Micro-beads array analyses indicate that Leishmania infantum amastigotes infection induces a higher secretion of several cytokines in these cells, and use of specific neutralizing antibodies revealed that the Leishmania-induced increase in HIV-1 replication is due to IL-6 and TNF-a

Read more

Summary

Introduction

Leishmaniasis is today recognized as one of the world’s most important parasitic diseases, threatening 350 million people in 88 countries [1]. At least 20 Leishmania species can induce various clinical manifestations better known as leishmaniasis. Infection by these trypanosomatid protozoan parasites may lead to a variety of symptoms, ranging from simple, self-healing skin ulcers to a severe, life-threatening visceral disease caused by the Leishmania donovani complex, including Leishmania infantum. VL is prevalent in HIV-1/ Leishmania co-infected individuals and is known to promote the development of AIDS-defining illness conditions and its clinical progression, diminishing the life expectancy of HIV-1-infected subjects. Visceral leishmaniasis has emerged as an important opportunistic disease among patients infected with HIV-1. Both HIV-1 and the protozoan parasite Leishmania can productively infect cells of the macrophage-dendritic cell lineage

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call